NCT01750593

Brief Summary

Thyroid nodules are common problems and although \> 95% are stated to be benign, they may cause some problems like hyperthyroidism, compression symptoms, and cosmesis associated with their function, size and localization. Especially for these nodules, patients undergo surgery and face up with the problems associated with surgical complications although they are not cancer. In some studies, radiofrequency ablation previously used for intrabdominal tumors like hepatic metastasis...,was stated to be efficient in the treatment of benign thyroid nodules and in some recurrent thyroid cancer cases. Therefore, the investigators decided to use this method in our patients having nodules like previously mentioned and see the efficacy and safety of the technique.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2013

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2012

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 17, 2012

Completed
4 months until next milestone

Study Start

First participant enrolled

April 1, 2013

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

November 28, 2013

Status Verified

November 1, 2013

Enrollment Period

9 months

First QC Date

October 7, 2012

Last Update Submit

November 27, 2013

Conditions

Keywords

radiofrequencythyroidnodule

Outcome Measures

Primary Outcomes (1)

  • Shrinkage of the thyroid nodule after radiofrequency ablation

    6 months

Secondary Outcomes (1)

  • Disappearance of the nodules in follow up

    1 year

Study Arms (1)

radiofrequency ablation of thyroid nodule

EXPERIMENTAL

Under ultrasonography the thyroid nodules will be ablated by radiofrequency ablation

Procedure: Radiofrequency ablation of the thyroid nodule

Interventions

Under USG control, the nodule will be ablated by radiofrequency with a needle that has an active tip of 1 cm.

radiofrequency ablation of thyroid nodule

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • the presence of subjective symptoms (foreign body sensation, neck discomfort or pain, compressive symptom) or cosmetic problems;
  • a poor surgical candidate or refusal to undergo surgery;
  • fine-needle aspiration cytology and US findings that were compatible with a benign nodule;
  • anxiety about a malignancy.

You may not qualify if:

  • a nodule less than 5 mm in size;
  • follicular neoplasm or malignancy on fine needle aspiration cytology (FNAC);
  • a nodule with the sonographic criteria for a malignancy (taller than wide, marked hypoechoic, microcalcifications, ill-defined margins), although FNAC was a benign result;
  • previous radiation or operation history to the head and neck; (5) previous sclerosing therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Bezmialem Vakif University

Istanbul, Istanbul, 34308, Turkey (Türkiye)

RECRUITING

Bezmialem Vakif University medical Faculty

Istanbul, 34308, Turkey (Türkiye)

RECRUITING

Bezmialem Vakif University

Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Thyroid NoduleThyroid Diseases

Condition Hierarchy (Ancestors)

Thyroid NeoplasmsEndocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System Diseases

Central Study Contacts

Erhan Aysan, Prof. Dr.

CONTACT

Yeliz Ersoy, Assoc.Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

October 7, 2012

First Posted

December 17, 2012

Study Start

April 1, 2013

Primary Completion

January 1, 2014

Study Completion

June 1, 2014

Last Updated

November 28, 2013

Record last verified: 2013-11

Locations